Skip to content
The Nexus
DossierENTITY

test-negative design

Coverage of test-negative design in the Nexus archive.

Earliest in view: Jun 23 · 22:44 UTCMost recent: Jun 23 · 22:44 UTC
Co-mentioned in this coverage
Centers for Disease Control and Preventionorganization2JAMA Network Openorganization2Jay Bhattacharyaperson2Natalie Deanperson2Emory Universityorganization2Morbidity and Mortality Weekly Reportorganization2U.S. Department of Health and Human Servicesorganization1
Recent coverage
  • HEALTHJun 23 · 22:44 UTCWDIV CLICKONDETROIT
    COVID-19 vaccine study that was blocked from CDC journal is published elsewhere

    A study on COVID-19 vaccine effectiveness, initially blocked from publication in a CDC journal, was published in JAMA Network Open. The study found vaccines reduced hospitalizations by 55% and emergency/urgent care visits by 50%, using a methodology criticized by CDC acting director Jay Bhattacharya but defended by public health researchers.

  • HEALTHJun 23 · 22:44 UTCWPLG LOCAL 10 MIAMI
    COVID-19 vaccine study that was blocked from CDC journal is published elsewhere

    A study on the effectiveness of the COVID-19 vaccine, initially blocked from publication in a CDC journal, found the vaccine to be 55% effective against hospitalizations and 50% effective against emergency department/urgent care visits. The study, published in JAMA Network Open, used a test-negative design methodology, which CDC acting director Jay Bhattacharya criticized for potential flaws, though public health researchers defend its reliability.